From Discovery to Market, We’ve Got You Covered.

As a leading partner in ophthalmic drug development, Altasciences has an outstanding track record formulating, testing, and manufacturing ophthalmic products. Working in tandem with our in-house preclinical, clinical, and bioanalytical teams, we ensure your compound advances safely and rapidly through each phase of drug development―from lead candidate selection to market.

Benefit from integrated CRO/CDMO services and a team that offers: 

•    Development and analytical testing of ophthalmic drug products in various dosage forms at our cGMP manufacturing facility
•    50 years of preclinical experience in ophthalmic safety testing
•    Three North American clinical research sites with over 500 beds and a database of 400,000+ participants
•    Bioanalytical expertise with rare and limited matrices, such as tears

Explore our full range of ophthalmic drug development services, or read the issue of The Altascientist to learn about the key considerations in each phase of ophthalmic drug development, including case studies.

Have questions? Consult with one of our experts. 

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Today marks a very special day for one of our own. March 27, 2018, was the day Michelle Newby received her brother’s cells to help her beat cancer. Watch as Michelle shares her story of beating cancer with the help of a clinical trial, and how that clinical trial inspired her career in contract research.

“Science is really important in my life. I’m alive because of science.” – Michelle Newby

Watch the video